Hair: Evidence-Based Supplement Guide

Six of the 72 people in Avelor with a saved stack hold something taken for hair. The best-selling supplement in this category has the weakest evidence for the thing it is sold for and the clearest evidence for something else entirely, and that sentence is the guide. **Biotin** is the supplement, and here is both halves. A review of its use in hair loss concluded that supplementation may benefit people with an actual biotin deficiency, or specific conditions such as brittle nail syndrome (PMID 28879195). It found those cases **uncommon**, and found a **lack of sufficient evidence for supplementation in healthy individuals**. What biotin has been clearly shown to do is interfere with immunoassays, particularly those measuring thyroid hormones and cardiac markers such as troponin (PMID 31613531). That produces false-positive or false-negative results, which can lead to inappropriate diagnostic or treatment decisions. So the most-taken hair supplement's best-documented effect is on your blood tests rather than on your hair. What does have evidence is not on a supplement shelf. A systematic review and meta-analysis of treatments for androgenetic alopecia concluded that minoxidil, finasteride and low-level laser therapy promote hair growth in men, and that minoxidil is effective in women (PMID 28396101). A further systematic review of management reaches the same place and favours a combined, individualised approach (PMID 38852607), with a comprehensive review of minoxidil specifically (PMID 34159872). These are medicines, and one of them has a documented harm profile worth reading first: a systematic review and meta-analysis examined sexual adverse effects with finasteride and dutasteride (PMID 30206635). The nutrient story is real but narrower than the marketing. A review of vitamins and minerals in hair loss found that the evidence supports supplementation where there is an actual deficiency alongside non-scarring hair loss, rather than generally (PMID 30547302). A systematic review of micronutrients in androgenetic alopecia identified B vitamins, vitamin D, iron, selenium and zinc as involved in its development and as potentially modifiable (PMID 39440586). A dietary systematic review pointed particularly at vitamin D and iron (PMID 40836838). Iron deficiency anaemia lists hair loss among its symptoms, and serum ferritin is described as the most efficient test for it (PMID 28189173). The pattern is the same as in the energy guide: the nutrient works if you are short of it. Two further things are worth knowing. Saw palmetto has a systematic review in alopecia reporting it may be an option, while calling for larger trials on its sole contribution (PMID 33313047). The wider natural-products literature remains preliminary (PMID 35044013, 30980598, 40627570). Collagen's evidence is for skin rather than hair, and it does not converge. One systematic review and meta-analysis reported positive effects on skin while identifying biases (PMID 37432180). A 2025 systematic review and meta-analysis found **no significant effect in high-quality studies** and concluded there is currently no clinical evidence supporting its use for skin ageing (PMID 40324552, 30681787).

1. **Get the cause identified before treating it.** Androgenetic alopecia and telogen effluvium are different problems with different answers (PMID 32607303, 31686886). 2. **Ask for a ferritin test rather than guessing about iron** (PMID 28189173). 3. **Review your existing supplements for things that cause hair loss** before adding another one (PMID 28613598). 4. **If you want the treatments with evidence, they are medicines**, and that is a conversation with a clinician rather than a purchase (PMID 28396101, 38852607). 5. **Tell whoever orders any blood test that you take biotin** (PMID 31613531).

Where the research supports a timeframe, telogen effluvium characteristically follows its trigger by around **three months** and resolves over months once the trigger is removed (PMID 32607303, 31686886). The androgenetic alopecia treatments are assessed over **months** and are ongoing rather than curative (PMID 28396101). No duration is offered for biotin in healthy people, because no benefit has been established for it to have (PMID 28879195).

- **Almost all the nutrient evidence is conditional on deficiency** (PMID 30547302, 39440586). A supplement correcting a deficiency you do not have has nothing to correct. - **The micronutrient review describes involvement in the condition, not a demonstrated treatment effect** (PMID 39440586). Those are different claims and the marketing conflates them. - **Saw palmetto's own review calls for larger trials isolating its contribution** (PMID 33313047), because it is usually studied inside combination products. - **Collagen's skin reviews disagree, and the more recent and more quality-stratified one is the negative one** (PMID 40324552, 37432180). Its hair evidence is thinner still. - **Hair loss during rapid weight loss, including on a GLP-1 medicine, is reported but not well characterised** (PMID 41998799, 38741261). No supplement has been shown to prevent it. - **Nothing here is evidence for scarring alopecia**, which is a different condition needing prompt specialist care.

- **Biotin can make your blood tests wrong.** It interferes with immunoassays including thyroid hormones and troponin, which can lead to wrong diagnoses or wrong treatment decisions (PMID 31613531). Tell **whoever orders any blood test** that you take it, and tell **emergency staff** if you are ever being assessed for chest pain. This matters more than anything else in this guide. - **Some supplements cause the hair loss they are sold to treat.** Excess vitamin A and retinoids are recognised causes of telogen effluvium, alongside beta-blockers, anticoagulants and several other medicines (PMID 28613598). Check what is in a hair product before adding it, and raise it with **a pharmacist**. - **Finasteride and dutasteride have a documented sexual adverse-effect profile** (PMID 30206635). Anyone considering them should have that conversation with **a prescriber** before starting, not after. - **Saw palmetto acts on the same hormonal pathway as those medicines** (PMID 33313047, 35044013). Tell **your prescriber** if you take it, particularly alongside any hormonal treatment or before a prostate-related blood test. - **Sudden patchy hair loss, hair loss with scalp scarring, pain, or scaling, or hair loss with other new symptoms needs a doctor**, not a supplement. Scarring alopecia is irreversible if left, which makes waiting the expensive option. - **Hair loss can be the visible sign of something treatable**, including iron deficiency and thyroid disease (PMID 28189173). That is a reason to be tested rather than a reason to buy.

Resolves **and** has a catalogue key, so it can be interaction-checked: - `avelor:sup:saw-palmetto` **Biotin has no supplement entity**, and this is the worst instance of that gap anywhere in these twenty guides. The catalogue already holds **five rows keyed on biotin**: one against laboratory testing generally, graded moderate, and four against thyroid medicines, **all graded major**, covering levothyroxine, liothyronine, Armour and liotrix. The evidence work is finished. The rows exist, carry text, and are not withheld. None of them can fire, because a user cannot save an ingredient the registry cannot produce. So the single most consequential sentence in this guide, that biotin can make a thyroid test or a troponin result wrong, is already written into the product as four major-severity rows. The person taking a hair supplement will never see it. This is the thyroid guide's finding approached from the opposite side. There the warning could not reach the patient on levothyroxine. Here it cannot reach the person holding the biotin. No supplement entity, and none is invented here: **biotin**, **collagen**, **keratin**, **silica**, **vitamin A**, **selenium**, **zinc** and **iron**. Iron's absence blocks a fifth guide and vitamin D's a sixth, and iron is the one nutrient here with a named test and a documented symptom.

| PMID | Title | | --- | --- | | 28879195 | "A Review of the Use of Biotin for Hair Loss" | | 31613531 | "Biotin Deficiency" | | 30547302 | "The Role of Vitamins and Minerals in Hair Loss: A Review" | | 39440586 | "Micronutrients and Androgenetic Alopecia: A Systematic Review" | | 40836838 | "Assessing the relationship between dietary factors and hair health: A systematic review" | | 28189173 | "Iron Deficiency Anemia" | | 28396101 | "The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis" | | 38852607 | "Management of androgenic alopecia: a systematic review of the literature" | | 34159872 | "Minoxidil: a comprehensive review" | | 30206635 | "Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis" | | 33313047 | "Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia" | | 35044013 | "Natural products for male androgenetic alopecia" | | 30980598 | "An overview of herbal alternatives in androgenetic alopecia" | | 40627570 | "Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions" | | 37432180 | "Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis" | | 40324552 | "Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" | | 30681787 | "Oral Collagen Supplementation: A Systematic Review of Dermatological Applications" | | 28613598 | "Telogen Effluvium" | | 32607303 | "Telogen Effluvium: A Review of the Literature" | | 31686886 | "Telogen effluvium: a comprehensive review" | | 41998799 | "GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling" | | 38741261 | "GLP-1 agonists and hair loss: a call for further investigation" |